Global Circulating Tumor Cells Prognostic Technologies Market to Exhibit 26.30% CAGR 2014-2020 due to Rising Prevalence of Cancer Worldwide
A new market research study, published by Transparency Market Research is titled “Circulating Tumor Cells (CTCs) Prognostic Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020.� This study provides a detailed analysis of the market, focusing on the current trends, major growth drivers, and barriers. The product segmentation, major geographical segments, and competitive landscape of the CTCs prognostic technologies market have also been mentioned in the research report. According to the study, in 2013, the global circulating tumor cells prognostic technologies market for was worth US$0.43 bn. The market is projected to register an impressive 26.30% CAGR between 2014 and 2020, reaching a value of US$2.16 bn by the end of 2020. Browse the full Circulating Tumor Cells (CTCs) Prognostic Technologies Market Technologies: Tumor Cell Enrichment (Filtration, Centrifugation and Immunological & Immunomagnetic Methods) & Tumor Cell Detection (Molecular Methods and Optical Methods) and Applications: Prostate Cancer, Breast Cancer, Colorectal Cancer and Others Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 report http://www.transparencymarketresearch.com/ctcs-prognostic-technologies-market.html Circulating tumor cells refer to specialized rare cells that are separated from the primary tumors, which further spread in the vasculature system of the human body. The dissemination of these cells further causes metastasis. CTCs act as a seed for the development of metastatic tumors in the vital distant organs; these tumors are considered as a major cause for cancer-related deaths. Technological developments in this field are one of the major factors contributing substantially towards the growth of the market. Furthermore, the growing prevalence rate of cancer, increasing evaluation of therapeutic monitoring, and high cost-benefit ratio are some of the other factors propelling the global CTCs prognostic technologies market. However, the lack of sensitivity and specificity and high costing associated with CTCs detection are projected to curtail the growth of the market in the coming years. By application, the global CTCs prognostic technologies market has been classified into prostate